# Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type II Diabetes Mellitus

Study · id `cardio:ct-nct01868646` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01868646](<https://clinicaltrials.gov/study/NCT01868646>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01868646

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 190 participants.

## Technical summary

Registry record NCT01868646. Randomized; quadruple masking; primary purpose supportive care. Start 2013-05-07 (actual); primary completion 2016-06-15 (actual). Results posted on 2019-03-04.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose supportive care
- Phase: Phase 4
- Enrolled: 190 participants (enrolled count; ClinicalTrials.gov record NCT01868646, source copy `cardio:ctgov-nct01868646-2019-05-31`, retrieved 2026-10-26)
- Started: 2013-05-07 (actual) (ClinicalTrials.gov record NCT01868646, source copy `cardio:ctgov-nct01868646-2019-05-31`, retrieved 2026-10-26)
- Primary completion: 2016-06-15 (actual) (ClinicalTrials.gov record NCT01868646, source copy `cardio:ctgov-nct01868646-2019-05-31`, retrieved 2026-10-26)
- Completion: 2016-06-15 (actual) (ClinicalTrials.gov record NCT01868646, source copy `cardio:ctgov-nct01868646-2019-05-31`, retrieved 2026-10-26)
- Results first posted: 2019-03-04 (ClinicalTrials.gov record NCT01868646, source copy `cardio:ctgov-nct01868646-2019-05-31`, retrieved 2026-10-26)
- Countries: Russia (ClinicalTrials.gov record NCT01868646, source copy `cardio:ctgov-nct01868646-2019-05-31`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01868646-2019-05-31`, retrieved 2026-10-26)

## The registry's words

- Brief title: Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type II Diabetes Mellitus
- Condition: Type II Diabetes Mellitus
- Intervention (Drug): Subetta
- Intervention (Drug): Placebo
- Lead sponsor: Materia Medica Holding
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)

## Provenance

Content hash: b65939b4b3b6092d9e1eaa2dbdbef20b9e875ae4603957e14dda9d481e677fb1
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
